Odysseas Kostas D 4
4 · Armata Pharmaceuticals, Inc. · Filed Dec 26, 2023
Insider Transaction Report
Form 4
Kostas Odysseas D
Director
Transactions
- Award
Stock Options (Right to Buy)
2023-12-21+10,461→ 10,461 totalExercise: $2.39Exp: 2033-12-21→ Common Stock (10,461 underlying)
Footnotes (1)
- [F1]The stock option vests immediately prior to the Company's 2024 annual shareholders meeting.